Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

4.71
+0.20004.43%
Pre-market: 4.790.0800+1.70%06:18 EST
Volume:24.53M
Turnover:114.12M
Market Cap:2.45B
PE:-2.64
High:4.77
Open:4.51
Low:4.46
Close:4.51
52wk High:12.36
52wk Low:3.79
Shares:520.64M
Float Shares:415.00M
Volume Ratio:0.54
T/O Rate:5.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7839
EPS(LYR):-1.6909
ROE:-91.06%
ROA:-42.20%
PB:2.34
PE(LYR):-2.79

Loading ...

Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Christopher Gibson proposes to sell 40,000 Shares, with a total value of approximately $208,400.
Oct 29, 2025

Major Issues Report

Form 8-K - Current report
Oct 23, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Gibson proposes to sell 100,000 shares, with a total value of approximately $570,000.
Oct 10, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Christopher Gibson proposes to sell 100,000 Shares, with a total value of approximately $604,000.
Sep 25, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Gibson proposes to sell 100,000 shares, with a total value of approximately $476,000.
Sep 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 26, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals's Officer Christopher Gibson proposes to sell 100,000 Shares, with a total value of approximately $484,000.
Aug 18, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Khan Najat proposes to sell 36,599 shares, with a total value of approximately $202,169.22.
Aug 11, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Christopher Gibson proposes to sell 617,875 Shares, with a total value of approximately $3.26 Million.
Aug 05, 2025

Major Issues Report

Form 8-K - Current report
Aug 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Major Issues Report

Form 8-K - Current report
Jun 10, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Major Issues Report

Form 8-K - Current report
May 05, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]